He; Haiying

Patent Applications and Registrations

Patent applications and USPTO patent grants for He; Haiying.The latest application filed is for "bicyclic compound as rip-1 kinase inhibitor and application thereof".

Company Profile

28.41.59

He; Haiying - Nanjing CN
HE; Haiying - Shanghai CN
HE; Haiying - Huizhou Guangdong
HE; Haiying - Pudong New Area Shanghai CN
He; Haiying - Lianyungang CN
He; Haiying - Jiangsu CN
He; Haiying - Huizhou City Guangdong
He; Haiying - Guangdong N/A CN
He; Haiying - Shenzhen CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bicyclic compound as a caspase inhibitor Grant 11,434,212 - Mou , et al. September 6, 2	2022-09-06
Bicyclic Compound As Rip-1 Kinase Inhibitor And Application Thereof App 20220242877 - WEI; Wei ; et al.	2022-08-04
Amorphous pyrrolidine derivative as PPAR agonist and preparation method thereof Grant 11,396,493 - Yuan , et al. July 26, 2	2022-07-26
Call Control Method And Apparatus, And Storage Medium And Terminal Device App 20220210269 - WANG; Dapeng ; et al.	2022-06-30
2,3-dihydro-1h-pyrrolizine-7-formamide Derivative And Application Thereof App 20220204510 - HE; Haiying ; et al.	2022-06-30
Lactam compound as FXR receptor agonist Grant 11,339,147 - He , et al. May 24, 2	2022-05-24
Composition Of Lanosterol Prodrug Compound, Preparation Method Therefor And Use Thereof App 20220133744 - Liu; Yizhi ; et al.	2022-05-05
Compound For Use In Retinal Diseases App 20220127243 - LI; Peng ; et al.	2022-04-28
Salt and crystal form of modified andrographolide compound and preparation method thereof Grant 11,299,482 - Xia , et al. April 12, 2	2022-04-12
Solid Form, Crystalline Form, And Crystal Form A Of Fxr Agonist, And Preparation Method And Application Thereof App 20220033391 - Li; Xiaolin ; et al.	2022-02-03
Process Route Of Compound Of Formula (iv), Crystal Form And Preparation Method Therefor App 20220024880 - LUO; Zhi ; et al.	2022-01-27
Bicyclic Compound as a Caspase Inhibitor App 20210332019 - MOU; Jianfeng ; et al.	2021-10-28
Crystal form of lanosterol prodrug compound and application thereof Grant 11,149,055 - Liu , et al. October 19, 2	2021-10-19
Salt And Crystal Form Of Modified Andrographolide Compound And Preparation Method Thereof App 20210284630 - XIA; Jianhua ; et al.	2021-09-16
Crystal Forms Of Thiazole Compound And Application Thereof App 20210276993 - SHI; Weihua ; et al.	2021-09-09
Crystal of a caspase inhibitor Grant 11,091,450 - Wu , et al. August 17, 2	2021-08-17
Crystal Form Of Lanosterol Prodrug Compound And Application Thereof App 20210246158 - LIU; Yizhi ; et al.	2021-08-12
Thieno[2,3-c]pyridazin-4(1h)-one Derivative And Application Thereof App 20210238190 - ZHENG; Xiaoping ; et al.	2021-08-05
Crystal Form Of Tri-cycle Compound And Application Thereof App 20210230188 - WANG; Jing ; et al.	2021-07-29
Method for preparing steroid derivative FXR agonist Grant 11,059,854 - Li , et al. July 13, 2	2021-07-13
Crystalline or amorphous form of steroid derivative FXR agonist, preparation method therefor and use thereof Grant 11,059,853 - Li , et al. July 13, 2	2021-07-13
Tri-cycle compound and applications thereof Grant 11,053,260 - He , et al. July 6, 2	2021-07-06
Ssao Inhibitor App 20210198220 - LUO; Zhi ; et al.	2021-07-01
Antiviral compounds Grant 11,021,444 - Wang , et al. June 1, 2	2021-06-01
Compounds for the treatment of paramyxovirus viral infections Grant 11,014,935 - Wang , et al. May 25, 2	2021-05-25
SSAO inhibitor Grant 11,001,563 - Luo , et al. May 11, 2	2021-05-11
Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereof Grant 10,981,860 - He , et al. April 20, 2	2021-04-20
Steroid Derivative FXR Agonist App 20210040140 - HE; Haiying ; et al.	2021-02-11
Crystal form of orexin receptor antagonist compound, and preparation method and application thereof Grant 10,912,775 - Wu , et al. February 9, 2	2021-02-09
Crystal form of orexin receptor antagonist compound, and preparation method and application thereof Grant 10,898,486 - Wu , et al. January 26, 2	2021-01-26
A Crystal Of A Caspase Inhibitor App 20210002235 - Wu; Songliang ; et al.	2021-01-07
Crystal form of orexin receptor antagonist compound, and preparation method and application thereof Grant 10,874,674 - Wu , et al. December 29, 2	2020-12-29
Steroid derivative FXR agonist Grant 10,875,888 - He , et al. December 29, 2	2020-12-29
Process for preparing 1-isobutyryl-1'-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[D]- imidazol-2-yl)methyl)spiro[azetidine-3,3'-indolin]-2'-one Grant 10,858,322 - Shi , et al. December 8, 2	2020-12-08
Amorphous Pyrrolidine Derivative As Ppar Agonist And Preparation Method Thereof App 20200339508 - Yuan; Zhiliang ; et al.	2020-10-29
Crystal Form Of Orexin Receptor Antagonist Compound, And Preparation Method And Application Thereof App 20200261453 - WU; Songliang ; et al.	2020-08-20
Crystal Form Of Orexin Receptor Antagonist Compound, And Preparation Method And Application Thereof App 20200261452 - WU; Songliang ; et al.	2020-08-20
Crystal Form Of Orexin Receptor Antagonist Compound, And Preparation Method And Application Thereof App 20200253972 - Kind Code	2020-08-13
Lanosterol prodrug compound and preparation method therefor and use thereof Grant 10,738,076 - Liu , et al. A	2020-08-11
Tri-cycle Compound And Applications Thereof App 20200247819 - Kind Code	2020-08-06
Crystalline Or Amorphous Form Of Steroid Derivative Fxr Agonist, Preparation Method Therefor And Use Thereof App 20200231621 - Li; Xiaolin ; et al.	2020-07-23
Method For Preparing Steroid Derivative Fxr Agonist App 20200231622 - Li; Xiaolin ; et al.	2020-07-23
Modified compound of andrographolide Grant 10,717,720 - He , et al.	2020-07-21
Process For Preparing 1-isobutyryl-1'-((1-(4,4,4-trifluoro-butyl)-4,5,6,7- Tetrahydro-1h-benzo[d]imidazol-2-yl)methyl)spiro[azet App 20200223802 - SHI; Weihua ; et al.	2020-07-16
Lactam Compound As Fxr Receptor Agonist App 20200190074 - HE; Haiying ; et al.	2020-06-18
Crystal form of orexin receptor antagonist compound, and preparation method and application thereof Grant 10,668,066 - Wu , et al.	2020-06-02
Thiazole derivative and applications thereof Grant 10,647,710 - He , et al.	2020-05-12
Crystal form B of 1-isobutyryl-1'-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[d]- imidazol-2-yl)methyl)spiro[azetidine-3,3'-indolin]-2'-one Grant 10,633,347 - Shi , et al.	2020-04-28
Ssao Inhibitor App 20200115352 - LUO; Zhi ; et al.	2020-04-16
Pyrrolidine derivatives as PPAR agonists Grant 10,526,320 - Yuan , et al. J	2020-01-07
Steroid Derivative FXR Agonist App 20190382437 - HE; Haiying ; et al.	2019-12-19
Thiazole Derivative And Applications Thereof App 20190375744 - He; Haiying ; et al.	2019-12-12
Antiviral Compounds App 20190263754 - WANG; Guangyi ; et al.	2019-08-29
Lanosterol Prodrug Compound And Preparation Method Therefor And Use Thereof App 20190256548 - LIU; Yizhi ; et al.	2019-08-22
Pyrrolidine Derivatives As Ppar Agonists App 20190225597 - Yuan; Zhiliang ; et al.	2019-07-25
Crystal Form A Of 1-isobutyryl-1'-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1h-benzo[d]- Imidazol-2-yl)methyl)spiro[azetidin App 20190218189 - SHI; Weihua ; et al.	2019-07-18
Caspase Inhibitor And Pharmaceutical Composition, Use And Therapeutic Method Thereof App 20190135733 - He; Haiying ; et al.	2019-05-09
Crystal form, preparation method and intermediate of dihydropyrido ring compound Grant 10,253,030 - He , et al.	2019-04-09
Salt form and crystal form of 1,2,5-thiadiazolidin-1,1-dioxide, preparation method thereof and intermediate Grant 10,227,339 - Li , et al.	2019-03-12
Crystal form A of 1-isobutyryl-1'-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo [d]imidazol-2-yl)methyl)spiro[azetidine-3,3'-indolin]-2'-one Grant 10,227,309 - Shi , et al.	2019-03-12
Quinolone derivatives as antibacterials Grant 10,160,726 - Fidalgo , et al. Dec	2018-12-25
Modified Compound Of Andrographolide App 20180346438 - HE; Haiying ; et al.	2018-12-06
Crystal Form, Preparation Method And Intermediate Of Dihydropyrido Ring Compound App 20180312512 - HE; Haiying ; et al.	2018-11-01
Piperidine derivatives as orexin receptor antagonist Grant 10,100,047 - He , et al. October 16, 2	2018-10-16
Crystal Form Of Orexin Receptor Antagonist Compound, And Preparation Method And Application Thereof App 20180235965 - WU; Songliang ; et al.	2018-08-23
Imidazole derivative used as antiviral agent and use thereof in preparation of medicament Grant 10,030,029 - He , et al. July 24, 2	2018-07-24
Anti-enterovirus 71 thiadiazolidine derivative Grant 9,988,361 - Li , et al. June 5, 2	2018-06-05
Method For Preparing Imidazole Derivative And Intermediate Thereof And Crystal Form App 20180141915 - SHI; Weihua ; et al.	2018-05-24
Salt Form And Crystal Form Of 1,2,5-thiadiazolidin-1,1-dioxide, Preparation Method Thereof And Intermediate App 20180141940 - LI; Peng ; et al.	2018-05-24
Dihydropyrimido fused ring derivative as HBV inhibitor Grant 9,938,301 - He , et al. April 10, 2	2018-04-10
Antiviral Compounds App 20180065932 - Wang; Guangyi ; et al.	2018-03-08
Imidazole Derivative Used As Antiviral Agent And Use Thereof In Preparation Of Medicament App 20180009820 - He; Haiying ; et al.	2018-01-11
Imidazole derivative used as antiviral agent and use therof in preparation of medicament Grant 9,850,251 - He , et al. December 26, 2	2017-12-26
Mobile terminal and ringtone playing method thereof Grant 9,794,400 - Lei , et al. October 17, 2	2017-10-17
Compounds For The Treatment Of Paramyxovirus Viral Infections App 20170283429 - Wang; Guangyi ; et al.	2017-10-05
Piperidine Derivatives As Orexin Receptor Antagonist App 20170233385 - HE; Haiying ; et al.	2017-08-17
Compounds for the treatment of paramoxyvirus viral infections Grant 9,724,351 - Wang , et al. August 8, 2	2017-08-08
Quinolone Derivatives As Antibacterials App 20170217897 - FIDALGO; Javier de Vicente ; et al.	2017-08-03
Dihydropyrimido Loop Derivative As Hbv Inhibitor App 20170197986 - HE; Haiying ; et al.	2017-07-13
Anti-enterovirus 71 Thiadiazolidine Derivative App 20170066732 - LI; Peng ; et al.	2017-03-09
Imidazole Derivative Used As Antiviral Agent And Use Therof In Preparation Of Medicament App 20160318943 - He; Haiying ; et al.	2016-11-03
Mobile Terminal And Ringtone Playing Method Thereof App 20160255190 - Lei; Ming ; et al.	2016-09-01
Compounds For The Treatment Of Paramoxyvirus Viral Infections App 20150238498 - Wang; Guangyi ; et al.	2015-08-27
Antiviral Compounds App 20150065504 - Wang; Guangyi ; et al.	2015-03-05
Thin-film transistor (TFT) array structure and liquid crystal display (LCD) panel thereof Grant 8,797,249 - Li , et al. August 5, 2	2014-08-05
TFT array substrate App 20140167160 - Chen; Shyh-Feng ; et al.	2014-06-19
Flat display panel and method for forming the same Grant 8,710,504 - Chen , et al. April 29, 2	2014-04-29
Thin-Film Transistor (TFT) Array Structure and Liquid Crystal Display (LCD) Panel Thereof App 20140092333 - Li; Shiqi ; et al.	2014-04-03
Compositions comprising quinazoline derivatives Grant 8,507,010 - Guo , et al. August 13, 2	2013-08-13
Flat Display Panel and Method for Forming the Same App 20130153905 - Chen; Shyh-Feng ; et al.	2013-06-20
LCD Panel and Method of Manufacturing the Same App 20130100005 - Shih; Ming Hung ; et al.	2013-04-25
Compositions Comprising Quinazoline Derivatives, Preparation Methods and Uses Thereof App 20110111059 - Guo; Jianhui ; et al.	2011-05-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.